Medicamen Life Sciences Private Limited, a active private limited company, was established on 12 August 2022 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24290DL2022PTC403121. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹10.00 Cr.
It upholds a compliant status. Employing 84 professional, Its leadership includes Rahul Bishnoi (Director), Kamal Kishore Pahwa (Managing Director), Ashwani Kumar Sharma (Director). Past directors included Kamal Kishore Pahwa, Pramod Kumar Sharma. It holds ₹10.42 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1009 & 1010, 10Th Floor Chiranjiv Tower, Nehru Place, New Delhi, New Delhi, Delhi, 110019.
U24290DL2022PTC403121
403121
12 August 2022
₹10.00 Cr
₹10.00 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Medicamen Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rahul Bishnoi | Director | 12 Aug 2022 | Current |
| Kamal Kishore Pahwa | Managing Director | 12 Aug 2022 | Current |
| Ashwani Kumar Sharma | Director | 12 Aug 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Nov 2024 | Past |
| Pramod Abcsdd | Director | 19 Nov 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medicamen Life Sciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2023, Medicamen Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹104,188,295.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Mar 2025 | Others | ₹9.00 Cr | Open |
| 19 Jan 2024 | Hdfc Bank Limited | ₹1.00 Cr | Open |
| 28 Jul 2023 | Hdfc Bank Limited | ₹4.19 M | Open |
Explore comprehensive loan charge details -
Medicamen Life Sciences has a workforce of 84 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Medicamen Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medicamen Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Others of Rs. 9.00 Cr registered on 28 Mar 2025 with Charge ID 101096664 was modified on 27 Jun 2025. was completed.
Progress on Parul Choudhary was appointed as a Company Secretary was appointed as a Company Secretary on 05 Apr 2025 & has been associated with this company since 7 months 28 days . was documented.
Chandan Kumar was appointed as a Cfo was appointed as a Cfo on 05 Apr 2025 & has been associated with this company since 7 months 28 days . was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 9.00 Cr with Charge ID 101096664 was registered on 28 Mar 2025. was documented.
The activity Medicamen Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Medicamen Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
/PRNewswire/ -- The "Global Folic Acid Market 2018-2022" report has been added to ResearchAndMarkets.com's offering. The Global Folic Acid Market to grow at a....
The CIN of Medicamen Life Sciences Private Limited is U24290DL2022PTC403121.
Medicamen Life Sciences Private Limited is headquartered at 1009 & 1010, 10Th Floor Chiranjiv Tower, Nehru Place, New Delhi, New Delhi, Delhi, 110019.
Medicamen Life Sciences Private Limited was incorporated on 12 August 2022.
The current directors of Medicamen Life Sciences Private Limited are
The primary industry of Medicamen Life Sciences Private Limited is Trade.
Medicamen Life Sciences Private Limited is unlisted.
The authorized capital of Medicamen Life Sciences Private Limited is ₹10.00 Cr, and the paid-up capital is ₹10.00 Cr.
The compliance status of Medicamen Life Sciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX